No Data
No Data
Vera Therapeutics Insiders Sell US$1.0m Of Stock, Possibly Signalling Caution
Vera Therapeutics Is Maintained at Overweight by JP Morgan
Vera Therapeutics Analyst Ratings
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $62
Vera Therapeutics, Inc.'s (NASDAQ:VERA) Intrinsic Value Is Potentially 88% Above Its Share Price
Express News | Vera Therapeutics Inc : JP Morgan Cuts Target Price to $62 From $65